Physician profile
Scott D Thomas
NPI 1144237975
$464.02
in general payments reported to CMS, 2019-2025
9 companies · $74.68 in 2025
The $74.68 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.41 · 2022: $152 · 2023: $55.50 · 2024: $152 · 2025: $74.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $282.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company Ltd. | $122.40 | 2022 | |
| Leo Pharma INC. | $101.73 | 2023-2025 | Adbry |
| E.R. Squibb & Sons, L.L.C. | $88.30 | 2024 | Opdivo |
| Sun Pharmaceutical Industries INC. | $70.27 | 2022-2024 | Ilumya |
| Regeneron Healthcare Solutions, INC. | $19.67 | 2025 | Dupixent |
| Merz North America, INC. | $16.63 | 2019 | |
| Pfizer INC. | $16.23 | 2025 | |
| Novartis Pharmaceuticals Corporation | $15.01 | 2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $13.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.